Here's Why Insulet Corporation's Investors Are Pumped
In response to the company's upbeat third-quarter results and raised guidance, shares of Insulet Corporation (NASDAQ: PODD), a medical device maker focused on diabetes and drug delivery, rose 16% as of 11:55 a.m. EDT on Friday.
Here are the key takeaways from Insulet's third quarter:
Management expects the good times to continue into the fourth quarter. The company is projecting revenue to land between $123 million and $126 million, which represents 20% at the midpoint. This range compares favorably to Wall Street's estimate of $120.9 million.
Source: Fool.com
Insulet Corp. Stock
€156.80
-0.760%
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Insulet Corp..
As a result the target price of 215 € shows a positive potential of 37.12% compared to the current price of 156.8 € for Insulet Corp..
